Findings on COVID-19 Discussed by Investigators at University of North Carolina Chapel Hill (Engineering a "muco-trapping" Ace2-immunoglobulin Hybrid With Picomolar Affinity As an Inhaled, Pan-variant Immunotherapy for Covid-19)

Press/Media: Research

PeriodMar 4 2024

Media coverage

1

Media coverage

  • TitleFindings on COVID-19 Discussed by Investigators at University of North Carolina Chapel Hill (Engineering a "muco-trapping" Ace2-immunoglobulin Hybrid With Picomolar Affinity As an Inhaled, Pan-variant Immunotherapy for Covid-19)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date4/3/24
    PersonsKwok Yung Yuen
View all 1
View less

Related content